Price
$207.49
Increased by +1.54%
Dollar volume (20D)
128.97 M
ADR%
2.06
Earnings report date
Feb 5, 2025
Shares float
98.34 M
Shares short
937.50 K [0.95%]
Shares outstanding
98.71 M
Market cap
20.17 B
Beta
0.85
Price/earnings
34.40
20D range
202.72 220.28
50D range
202.72 234.37
200D range
196.38 247.59

STERIS plc provides infection prevention products and services worldwide.

It operates through three segments: Healthcare, Applied Sterilization Technologies (AST), and Life Sciences.

The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in surgical tables, lights, and connectivity solutions, as well as equipment management services.

It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument, devices, and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services.

The AST segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of contract sterilization and laboratory facilities, as well as integrated sterilization equipment and control systems to medical device manufacturers and research institutions.

The Life Sciences segment designs, manufactures, and sells consumable products, such as pharmaceutical detergents, cleanroom disinfectants and sterilants, pharmaceutical grade and research sterilizers and washers, sterility assurance and maintenance products, vaporized hydrogen peroxide room decontamination systems and sterilizers, and high purity water and pure steam generators.

This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services.

It serves its products and services to hospitals, other healthcare providers, and pharmaceutical manufacturers.

The company was founded in 1985 and is headquartered in Mentor, Ohio.

  • Quarterly earnings
  • Annual earnings
Reported date EPSChange YoY EstimateSurprise
Nov 6, 24 2.14
Increased by +5.42%
2.12
Increased by +0.94%
Aug 6, 24 2.14
Increased by +7.00%
1.98
Increased by +8.08%
May 8, 24 2.58
Increased by +12.17%
2.35
Increased by +9.79%
Feb 7, 24 2.22
Increased by +9.90%
2.17
Increased by +2.30%
Nov 7, 23 2.03
Increased by +2.01%
2.00
Increased by +1.50%
Aug 1, 23 2.00
Increased by +5.26%
1.87
Increased by +6.95%
May 10, 23 2.30
Increased by +12.75%
2.15
Increased by +6.98%
Feb 8, 23 2.02
Decreased by -4.72%
2.19
Decreased by -7.76%
  • Quarterly financials
  • Annual financials
Fiscal ending date RevenueChange YoY IncomeChange YoY ProfitChange YoY
Sep 30, 24 1.33 B
Decreased by -1.00%
150.03 M
Increased by +30.10%
Increased by +11.29%
Increased by +31.42%
Jun 30, 24 1.28 B
Decreased by -0.39%
145.40 M
Increased by +17.68%
Increased by +11.36%
Increased by +18.15%
Mar 31, 24 1.42 B
Increased by +2.49%
-1.38 M
Decreased by -100.74%
Decreased by -0.10%
Decreased by -100.72%
Dec 31, 23 1.40 B
Increased by +14.77%
140.74 M
Increased by +14.12%
Increased by +10.08%
Decreased by -0.57%
Sep 30, 23 1.34 B
Increased by +11.82%
115.32 M
Increased by +136.58%
Increased by +8.59%
Increased by +132.72%
Jun 30, 23 1.28 B
Increased by +11.07%
123.55 M
Increased by +11.56%
Increased by +9.62%
Increased by +0.44%
Mar 31, 23 1.38 B
Increased by +14.38%
187.22 M
Increased by +259.68%
Increased by +13.52%
Increased by +214.45%
Dec 31, 22 1.22 B
Increased by +0.58%
123.33 M
Decreased by -13.82%
Increased by +10.14%
Decreased by -14.31%
Open dropdown content
Open dropdown content
DAILY
WEEKLY
MONTHLY